QTLs in Region (mRatBN7.2)
| 61408 | Scl23 | Serum cholesterol level QTL 23 | | 0.0005 | blood HDL phospholipid amount (VT:0010504) | serum high density lipoprotein phospholipid level (CMO:0001567) | 4 | 1 | 27716890 | Rat |
| 2302371 | Stl22 | Serum triglyceride level QTL 22 | 5.15 | | blood triglyceride amount (VT:0002644) | serum triglyceride level (CMO:0000360) | 4 | 5218294 | 57114705 | Rat |
| 2303168 | Bp330 | Blood pressure QTL 330 | 4.25 | 0.017 | arterial blood pressure trait (VT:2000000) | mean arterial blood pressure (CMO:0000009) | 4 | 5214602 | 146446691 | Rat |
| 9589046 | Scfw2 | Subcutaneous fat weight QTL 2 | 5.54 | 0.001 | subcutaneous adipose mass (VT:1000472) | abdominal subcutaneous fat pad weight (CMO:0002069) | 4 | 1 | 31934116 | Rat |
| 8552903 | Pigfal2 | Plasma insulin-like growth factor 1 level QTL 2 | 7.3 | | blood insulin-like growth factor amount (VT:0010479) | plasma insulin-like growth factor 1 level (CMO:0001299) | 4 | 1 | 31934116 | Rat |
| 724557 | Plsm1 | Polydactyly-luxate syndrome (PLS) morphotypes QTL 1 | | 0.0003 | forelimb integrity trait (VT:0010562) | front foot phalanges count (CMO:0001947) | 4 | 1 | 27716890 | Rat |
| 9590100 | Sffal4 | Serum free fatty acids level QTL 4 | 7.36 | 0.05 | blood free fatty acid amount (VT:0001553) | plasma free fatty acids level (CMO:0000546) | 4 | 1 | 31934116 | Rat |
| 61351 | Bp33 | Blood pressure QTL 33 | | 0.0018 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 1 | 27716890 | Rat |
| 61415 | Eae11 | Experimental allergic encephalomyelitis QTL 11 | 2.9 | | nervous system integrity trait (VT:0010566) | post-insult time to onset of experimental autoimmune encephalomyelitis (CMO:0001422) | 4 | 1 | 39505420 | Rat |
| 1641905 | Colcr1 | Colorectal carcinoma resistance QTL 1 | 4.3 | 0.0003 | intestine integrity trait (VT:0010554) | benign colorectal tumor surface area measurement (CMO:0001799) | 4 | 1 | 29494328 | Rat |
| 1357341 | Gluco5 | Glucose level QTL 5 | 6.4 | | adipocyte free fatty acid secretion trait (VT:0010465) | absolute change in adipocyte free fatty acid secretion per unit volume (CMO:0001446) | 4 | 1 | 33250345 | Rat |
| 619616 | Bp79 | Blood pressure QTL 79 | | 0.0292 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 5214602 | 78882945 | Rat |
| 1357343 | Gluco4 | Glucose level QTL 4 | | 0.00002 | adipocyte glucose uptake trait (VT:0004185) | adipocyte maximal glucose uptake to basal glucose uptake ratio (CMO:0000874) | 4 | 1 | 33250345 | Rat |
| 1358201 | Gluco12 | Glucose level QTL12 | 1.6 | | adipocyte glucose uptake trait (VT:0004185) | adipocyte maximal glucose uptake (CMO:0000870) | 4 | 5218392 | 29593287 | Rat |
| 738021 | Hcar13 | Hepatocarcinoma resistance QTL 13 | 4.3 | | liver integrity trait (VT:0010547) | liver nonremodeling tumorous lesion volume to total liver volume ratio (CMO:0001464) | 4 | 1 | 32584199 | Rat |
| 1358203 | Stl19 | Serum triglyceride level QTL 19 | 2.8 | 0.002 | blood triglyceride amount (VT:0002644) | serum triglyceride level (CMO:0000360) | 4 | 5218294 | 65958103 | Rat |
| 631642 | Stl2 | Serum triglyceride level QTL 2 | 3.3 | | blood triglyceride amount (VT:0002644) | serum triglyceride level (CMO:0000360) | 4 | 5219178 | 56647776 | Rat |
| 61333 | Gluco16 | Glucose level QTL 16 | 4.3 | 0.00001 | adipocyte glucose uptake trait (VT:0004185) | absolute change in adipocyte glucose uptake (CMO:0000873) | 4 | 1 | 30372989 | Rat |
| 634323 | Hc2 | Hypercalciuria QTL 2 | 2.15 | | urine calcium amount (VT:0002985) | urine calcium excretion rate (CMO:0000763) | 4 | 210796 | 45210796 | Rat |
| 9589097 | Slep11 | Serum leptin concentration QTL 11 | 5.09 | 0.001 | blood leptin amount (VT:0005667) | plasma leptin level (CMO:0000781) | 4 | 1 | 31934116 | Rat |
